Minimally Invasive Surgery Market Research Reports & Industry Analysis
Minimally invasive surgery allows doctors to perform many complicated operations with small incisions using specialized instruments and technologies that reduce trauma and enable shorter recovery times. The minimally invasive surgery market is expected to grow at a rapid pace in the coming years as technology continues to advance. For an in-depth understanding of this complex market, turn to the research available on MarketResearch.com which covers a wide range of segments based on product, application, and geography.
Minimally Invasive Surgery Market Reports
- Learn about key market characteristics, size and growth, the competitive landscape, and industry trends.
- Identify growth segments and understand what forces will shape the minimally invasive surgery market going forward.
- Discover the competitive strategies of key companies such as GE Healthcare, Siemens Healthineers, Philips Healthcare, Medtronic, and more.
Rely on MarketResearch.com for Accurate Data
By sourcing research from MarketResearch.com, you benefit from the expertise of a trusted name with more than 20 years of experience in the field of market research. Our loyal and established client base includes top investment banks, management consulting firms, and leading multinational companies in the Fortune 500. We bring together reports from hundreds of premier firms to offer convenient access to critical data and insights at the best prices available. Browse our collection of minimally invasive surgery market research reports today.
Minimally Invasive Surgery Industry Research & Market Reports
-
Colonoscopy Devices
... CAGR of 4.1% over the analysis period 2024-2030. Visualization Systems, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More
-
Anal Fistula Treatment
... at a CAGR of 4.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$207.5 Million While China is Forecast to Grow at 4.1% CAGR The Anal Fistula Treatment market in the U.S. ... Read More
-
Radiosurgery and Radiotherapy Robots
... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. X-Ray Based Robots, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$3.2 Billion by ... Read More
-
Liquid Biopsy
... CAGR of 17.9% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$12.8 Billion by the end of the analysis ... Read More
-
Fluid Management Systems
... at a CAGR of 10.6% over the analysis period 2024-2030. Fluid Management Systems, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$14.1 Billion by the end ... Read More
-
Biopsy Devices
... CAGR of 4.5% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$4.5 Billion by the end of the analysis period. ... Read More
-
Capsule Endoscope Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. Small Bowel Capsule, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$426.9 Million by the end ... Read More
-
Gastrointestinal (GI) Endoscopy Devices
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$25.5 ... Read More
-
Ligation Devices
... CAGR of 5.9% over the analysis period 2024-2030. Accessories, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Aspiration & Biopsy Needles
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Biopsy Needles, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.0 Billion by the ... Read More
-
Biopsy Needles
... CAGR of 5.7% over the analysis period 2024-2030. Vacuum-Assisted, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$971.8 Million by the end of the analysis period. ... Read More
-
Minimally Invasive Vertebral Compression Fracture Repair
... reach US$1.3 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach ... Read More
-
Tumor Ablation Technologies
... at a CAGR of 13.3% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Urolithiasis Management Devices
... at a CAGR of 5.5% over the analysis period 2024-2030. Extracorporeal Shock Wave Lithotripsy (ESWL), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.1 Billion by ... Read More
-
Viscosupplementation
... 7.9% over the analysis period 2024-2030. Single Injection, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Atherectomy Devices
... CAGR of 9.4% over the analysis period 2024-2030. Support Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$142.9 Million by the end of the analysis ... Read More
-
Angioplasty Balloons
... CAGR of 3.9% over the analysis period 2024-2030. Normal Balloons, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.1 Billion by the end of the analysis ... Read More
-
Fluoroscopy and Mobile C-Arms
... 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Fluoroscopy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end ... Read More
-
Kidney Stone Management Devices
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end ... Read More
-
Lacrimal Duct Stent Tubes
... 2030, growing at a CAGR of 2.1% over the analysis period 2024-2030. Bicanalicular Tubes, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$35.0 Million by the ... Read More
-
Minimally Invasive Thoracic Surgery
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Lobectomy, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$3.2 Billion by the end ... Read More
-
Flexible and Semi-Rigid Ureteroscopy
... 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Flexible, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$54.1 Billion by the end ... Read More
-
Bronchoscopes
... 5.9% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in ... Read More
-
Percutaneous Nephrolithotomy
... CAGR of 4.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$90.1 Million While China is Forecast to Grow at 6.7% CAGR The Percutaneous Nephrolithotomy market in the U.S. is estimated at ... Read More
Research Assistance
